{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:23:58Z","timestamp":1785605038312,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":285,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neuropharm.2022.109174","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T11:17:08Z","timestamp":1656328628000},"page":"109174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-3037","authenticated-orcid":false,"given":"S.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Henningfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2022.109174_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109174_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207820","article-title":"The national Institutes of health measure of healing experience of all life stressors (NIH-HEALS): factor analysis and validation","volume":"13","author":"Ameli","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109174_bib3","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClini. Med."},{"key":"10.1016\/j.neuropharm.2022.109174_bib4","article-title":"United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020","volume":"99","author":"Barnett","year":"2021","journal-title":"Int. J. Drug Pol."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109174_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109174_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1176\/appi.psy.45.6.483","article-title":"Diagnostic criteria for psychosomatic research and psychosocial variables in breast cancer patients","volume":"45","author":"Grassi","year":"2004","journal-title":"Psychosomatics"},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109174_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109174_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109174_bib9","first-page":"129","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"Int. Pharmacop."},{"key":"10.1016\/j.neuropharm.2022.109174_bib10","series-title":"The Human Encounter with Death","author":"Grof","year":"1977"},{"key":"10.1016\/j.neuropharm.2022.109174_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.genhosppsych.2019.04.013","article-title":"Frequency of demoralization and depression in cancer patients","volume":"60","author":"Ignatius","year":"2019","journal-title":"Gen. Hosp. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109174_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0973-1075.25913","article-title":"Depression and demoralization as distinct syndromes: preliminary data from a cohort of advanced cancer patients","volume":"12","author":"Jacobsen","year":"2006","journal-title":"Indian J. Palliat. Care"},{"key":"10.1016\/j.neuropharm.2022.109174_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109174_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1017\/S1478951515001364","article-title":"Prevalence and factors associated with demoralization syndrome in patients with advanced disease: results from a cross-sectional Portuguese study","volume":"14","author":"Juli\u00e3o","year":"2016","journal-title":"Palliat. Support Care"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109174_bib15","first-page":"80","article-title":"LSD and the dying patient","volume":"26","author":"Kast","year":"1966","journal-title":"Chicago Med. Sch. Q."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109174_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF01575629","article-title":"Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide","volume":"41","author":"Kast","year":"1967","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.neuropharm.2022.109174_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1213\/00000539-196405000-00013","article-title":"Study of lysergic acid diethylamide as an analgesic agent","volume":"43","author":"Kast","year":"1964","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2022.109174_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/082585971403000402","article-title":"Demoralization: a life-preserving diagnosis to make for the severely medically ill","volume":"30","author":"Kissane","year":"2014","journal-title":"J. Palliat. Care"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109174_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cpr.2007.07.013","article-title":"Treatment of existential distress in life threatening illness: a review of manualized interventions","volume":"28","author":"LeMay","year":"2008","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109174_bib20","series-title":"Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis","author":"Levit","year":"2013"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109174_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4088\/JCP.v66n0317","article-title":"Assessing demoralization and depression in the setting of medical disease","volume":"66","author":"Mangelli","year":"2005","journal-title":"J. Clin. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109174_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109174_bib23","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/pon.4824","article-title":"Relationship of demoralization with anxiety, depression, and quality of life: a Southern European study of Italian and Portuguese cancer patients","volume":"27","author":"Nanni","year":"2018","journal-title":"Psycho Oncol."},{"key":"10.1016\/j.neuropharm.2022.109174_bib24","author":"Nccn"},{"key":"10.1016\/j.neuropharm.2022.109174_bib25","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"6","author":"Ostuzzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2022.109174_bib26","first-page":"144","article-title":"LSD-assisted psychotherapy with terminal cancer patients","volume":"9","author":"Pahnke","year":"1969","journal-title":"Curr. Psychiatr. Ther."},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109174_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/jpm.2009.0142","article-title":"Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference","volume":"12","author":"Puchalski","year":"2009","journal-title":"J. Palliat. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109174_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01532413","article-title":"Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy","volume":"17","author":"Richards","year":"1978","journal-title":"J. Relig. Health"},{"issue":"14","key":"10.1016\/j.neuropharm.2022.109174_bib29","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/cncr.30012","article-title":"Refinement and revalidation of the demoralization scale: the DS-II-external validity","volume":"122","author":"Robinson","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109174_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","article-title":"Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress","volume":"30","author":"Ross","year":"2018","journal-title":"Int. Rev. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109174_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol. Translat. Sci."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109174_bib32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"22","key":"10.1016\/j.neuropharm.2022.109174_bib33","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109174_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","article-title":"Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies","volume":"7","author":"Simard","year":"2013","journal-title":"J. Cancer Survivorship."},{"key":"10.1016\/j.neuropharm.2022.109174_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/PROM.S118696","article-title":"An assessment of meaning in life-threatening illness: development of the Healing Experience in All Life Stressors (HEALS)","volume":"8","author":"Sloan","year":"2017","journal-title":"Patient Relat. Outcome Meas."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109174_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpainsymman.2017.07.028","article-title":"State of the science of spirituality and palliative care research Part I: definitions, measurement, and outcomes","volume":"54","author":"Steinhauser","year":"2017","journal-title":"J. Pain Symptom Manag."},{"issue":"17","key":"10.1016\/j.neuropharm.2022.109174_bib37","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1002\/cncr.30749","article-title":"The association of demoralization with mental disorders and suicidal ideation in patients with cancer","volume":"123","author":"Vehling","year":"2017","journal-title":"Cancer"},{"issue":"35","key":"10.1016\/j.neuropharm.2022.109174_bib38","article-title":"Are spiritual interventions beneficial to patients with cancer?: a meta-analysis of randomized controlled trials following PRISMA","volume":"97","author":"Xing","year":"2018","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109174_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41467-018-08170-1","article-title":"Suicide among cancer patients","volume":"10","author":"Zaorsky","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822002337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822002337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:18:46Z","timestamp":1758439126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822002337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":39,"alternative-id":["S0028390822002337"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109174","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109174"}}